Clinical Trial Update: Serum IGF-1 and IGF-1Ec in Malignancy Assessment

View source ↗

Summary

This clinical trial assesses serum IGF-1 and IGF-1Ec as biomarkers in malignancy; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumors

Snippet

Sponsor: Çanakkale Onsekiz Mart University | Conditions: Cancer, Solid Tumor Malignancies | Status: ACTIVE_NOT_RECRUITING